AFRO-NETS> Encounter counterfeit drugs? -- The WHO will like to hear from you

[A Odutola <chpss_abo@yahoo.com>]

Encounter counterfeit drugs? -- The WHO will like to hear from you
------------------------------------------------------------------

* Reporting detected counterfeit drugs
http://www.who.int/medicines/organization/qsm/activities/qualityassurance/counterfeit/reporting_cd.shtml

"Combating the problem of counterfeit drugs is a shared responsibil-
ity in which all concerned parties: government agencies, pharmaceuti-
cal industries, drug suppliers, healthcare providers, professional 
associations, consumers and nongovernmental organizations and inter-
national organizations have to participate.

In order to design and implement appropriate national as well inter-
national anti-counterfeiting measures, it is necessary to have access 
to reliable information on the nature and magnitude of the problem. 
In turn this requires the availability of an effective information 
exchange system between all the concerned parties.

In order to promote this, WHO in 1996 developed and distributed two 
types of Counterfeit Drugs Reporting Forms: Form DRS/CFD/RF.1 and 
Form DRS/CFD/RF.2 to all its Member States. These forms have now been 
revised and are available as Form A (CFD/RF.1) and Form B (CFD/RF.2). 
National Drug Regulatory Authorities, Anti-counterfeiting Liaison Of-
ficers, and others who detect counterfeit drugs are therefore encour-
aged to fill these forms and send them to the address indicated be-
low.

Both Form A (English -- French) and Form B (English -- French) need 
to be filled out for each case of counterfeit drug that is detected. 
A case is defined by the stated active ingredient, dosage form, the 
trade name on the label and batch number. If any one of these is dif-
ferent then the case will be considered to be different.

Form A provides general information about the reporting authority, 
country where the drug has been detected, date and site of detection, 
etc., whereas Form B provides information about the detected drug, 
active ingredient, trade name, dosage form, batch number, etc.

WHO will consolidate the information received on quarterly basis and 
post it on its counterfeit drugs notification website.

For enquiries please contact: 
Mr Eshetu Wondemagegnehu 
Quality Assurance and Safety of Medicines
Essential Drugs and Medicines Policy (EDM)
World Health Organization
CH-1211 Geneva 27, Switzerland
Tel: +41-22-791-3743
Fax: +41-22-791-4730 


Links to reporting forms:

Form A - (English):
http://www.who.int/medicines/organization/qsm/activities/qualityassurance/counterfeit/cf_engforma.pdf

Form A - (French): 
http://www.who.int/medicines/organization/qsm/activities/qualityassurance/counterfeit/cf_frenchforma.pdf


Form B - (English):
http://www.who.int/medicines/organization/qsm/activities/qualityassurance/counterfeit/cf_engformb.pdf

Form B - (French): 
http://www.who.int/medicines/organization/qsm/activities/qualityassurance/counterfeit/cf_frenchformb.pdf


--
A. Odutola
mailto:chpss_abo@yahoo.com

--
To send a message to AFRO-NETS, write to: afro-nets@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe afro-nets OR unsubscribe afro-nets
To contact a person, send a message to: afro-nets-help@usa.healthnet.org
Information and archives: http://www.afronets.org